RankingsPricing
  1. US-listed companies
  2. STAAR SURGICAL CO
  3. Financials
  4. Research & development

STAAR SURGICAL COSTAA

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 27, 202454+21.56%
Dec 29, 202344+23.39%
Dec 30, 202236+6.26%
Dec 31, 202134+6.09%
Jan 1, 202132+26.17%
Jan 3, 202025+14.84%
Dec 28, 201822+15.23%
Dec 29, 201719-5.80%
Dec 30, 201620+37.48%
Jan 1, 201615+19.40%
Jan 2, 201512+84.30%
Jan 3, 20147+4.10%
Dec 28, 20126+9.82%
Dec 30, 20116

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)